The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS.
Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.
Her death certificate, seen by the BBC, lists multiple organ failure, septic shock and pancreatitis as the immediate cause of death – but “the use of prescribed tirzepatide” is also recorded as a contributing factor.
Nurse’s death linked
It is thought to be the first death officially linked to the drug in the UK.
Ms McGowan worked as a nurse at University Hospital Monklands in Airdrie for more than 30 years.
The popular bed manager had often discussed her weight loss attempts with close friends, but the emergence of new weight-loss jabs seemed to her to offer better chances of success.
After researching Mounjaro and seeking medical advice, she purchased a prescription via a registered online pharmacy.
The drug typically costs between £150 and £200 for a four-week supply and can be purchased from any registered pharmacy in the UK.
Days after her second injection she began experiencing severe stomach pains and sickness, so she went to A&E at Monklands – where her colleagues battled to save her life. Jade Campbell, Ms McGowan’s niece, was with her when she died.
Source: BBC
In other news – King Charles holds crucial meeting at Buckingham Palace
King Charles Hosts Crucial Meeting at Buckingham Palace Amid Growing Challenges. In a significant development, King Charles convened a high-profile meeting at Buckingham Palace, underscoring his proactive approach to addressing both national and international challenges.
The gathering brought together senior members of the royal household, key government officials, and influential figures, reflecting the monarch’s commitment to fostering stability and unity during pivotal times. Read more
